Inhalers – Pipeline Products by Stage of Development 16
Inhalers – Pipeline Products by Segment 17
Inhalers – Pipeline Products by Territory 18
Inhalers – Pipeline Products by Regulatory Path 20
Inhalers – Pipeline Products by Estimated Approval Date 21
Inhalers – Ongoing Clinical Trials 22
Inhalers Companies – Pipeline Products by Stage of Development 23
Inhalers – Pipeline Products by Stage of Development 26
1nhaler Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
Single-Use Dry Powder Inhaler – Product Status 29
Single-Use Dry Powder Inhaler – Product Description 29
Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
INBRIJA – Product Status 30
INBRIJA – Product Description 30
PLUMIAZ Nasal Spray Device – Product Status 31
PLUMIAZ Nasal Spray Device – Product Description 31
Acorda Therapeutics Inc – Ongoing Clinical Trials Overview 32
INBRIJA – Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson’s Disease Patients 33
Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
g60 Dry Powder Inhaler – Product Status 34
g60 Dry Powder Inhaler – Product Description 34
Aerami Therapeutics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 35
AFINA Smart Inhaler – Product Status 35
AFINA Smart Inhaler – Product Description 35
Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
resQhaler – Product Status 36
resQhaler – Product Description 36
AKELA Pharma Inc. (Formerly LAB International, Inc.) (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37
Fentanyl TAIFUN Inhaler – Product Status 37
Fentanyl TAIFUN Inhaler – Product Description 37
AsMedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38
Reusable Inhaler – Product Status 38
Reusable Inhaler – Product Description 38
Ayrton Saunders Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
VOKE 2.0 – Product Status 39
VOKE 2.0 – Product Description 39
Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 40
Ciprofloxacin Dry Powder Inhaler – Product Status 40
Ciprofloxacin Dry Powder Inhaler – Product Description 40
Claricare – Product Status 41
Claricare – Product Description 41
Belhaven Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Nasdepi – Product Status 42
Nasdepi – Product Description 42
Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Mark2 Device – Product Status 43
Mark2 Device – Product Description 43
Cambridge Healthcare Innovations Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
aeolus Dry-Powder Inhaler (DPI) – Product Status 44
aeolus Dry-Powder Inhaler (DPI) – Product Description 44
Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
Complex Inhaler – Product Status 45
Complex Inhaler – Product Description 45
Smart Inhaler – Product Status 46
Smart Inhaler – Product Description 46
Covinhaler LLP Pipeline Products & Ongoing Clinical Trials Overview 47
Pocket Inhaler – COVID-19 – Product Status 47
Pocket Inhaler – COVID-19 – Product Description 47
Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 48
Intranasal Dry Powder Inhaler – Product Status 48
Intranasal Dry Powder Inhaler – Product Description 48
De Motu Cordis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
DMC Inhaler – Product Status 49
DMC Inhaler – Product Description 49
De Motu Cordis Pty Ltd – Ongoing Clinical Trials Overview 50
DMC Inhaler – A Phase 1, 2-Part Study in Healthy Male and Female Participants; Part 1 – A Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose-Escalation Study of Inhaled DMC-IH1; Part 2 – An Open-Label, 3-Arm Study Assessing the Carryover Effects of Inhaled (DMC-IH1) and Intramuscular (EpiPen) Epinephrine 51
DMK Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 52
APC-4000 Fluticasone Dry Powder Inhaler – Product Status 52
APC-4000 Fluticasone Dry Powder Inhaler – Product Description 52
Drexel University Pipeline Products & Ongoing Clinical Trials Overview 53
BREATHE Inhaler – Product Status 53
BREATHE Inhaler – Product Description 53
Engage Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Staccato Alprazolam – Product Status 54
Staccato Alprazolam – Product Description 54
Findair Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 55
FindAir ONE Smart Inhaler – Product Status 55
FindAir ONE Smart Inhaler – Product Description 55
Findair Sp zoo – Ongoing Clinical Trials Overview 56
FindAir ONE Smart Inhaler – Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease 57
FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 58
Smart Inhaler – Product Status 58
Smart Inhaler – Product Description 58
Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
Tiogiva – Product Status 59
Tiogiva – Product Description 59
GSK plc Pipeline Products & Ongoing Clinical Trials Overview 60
Gemini Multi-Dose Combination Inhaler – Product Status 60
Gemini Multi-Dose Combination Inhaler – Product Description 60
Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
Papillon DPI – Product Status 61
Papillon DPI – Product Description 61
Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview 62
ICOcap – Product Status 62
ICOcap – Product Description 62
ICOone – Product Status 63
ICOone – Product Description 63
ICOone – Oxytocin – Product Status 63
ICOone – Oxytocin – Product Description 63
ICOpre – Product Status 64
ICOpre – Product Description 64
ICOres – Product Status 64
ICOres – Product Description 65
Multi-Dose Delivery Device – Product Status 65
Multi-Dose Delivery Device – Product Description 65
Iconovo AB – Ongoing Clinical Trials Overview 66
ICOone – A Feasibility Study with Affilogic for the Development of Inhalable Nanofitin-based Biotherapies 67
ICOone – Oxytocin – A Randomized, Single-Center, Partially Single-Blind Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Single and Repeated Doses of Oxytocin Administered via Inhalation or Intravenous or Intramuscular Administration in Healthy Female Participants 68
Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Dry Powder Inhaler 1 – Product Status 69
Dry Powder Inhaler 1 – Product Description 69
Dry Powder Inhaler 2 – Product Status 70
Dry Powder Inhaler 2 – Product Description 70
Tiotropium DPI – Product Status 70
Tiotropium DPI – Product Description 70
MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview 71
Afrezza – Pediatric Use – Product Status 71
Afrezza – Pediatric Use – Product Description 71
Afrezza Inhaler – Product Status 72
Afrezza Inhaler – Product Description 72
Treprostinil Technosphere – Product Status 72
Treprostinil Technosphere – Product Description 73
MannKind Corp – Ongoing Clinical Trials Overview 74
Afrezza Inhaler – INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes 75
Medihale Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76
Toucan Multi-Dose Inhaler – Product Status 76
Toucan Multi-Dose Inhaler – Product Description 76
Monash University Pipeline Products & Ongoing Clinical Trials Overview 77
Aerosol Delivery System – Product Status 77
Aerosol Delivery System – Product Description 77
Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 78
NKTR-061 – Product Status 78
NKTR-061 – Product Description 78
North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 79
Smart Inhaler System – Product Status 79
Smart Inhaler System – Product Description 79
Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 80
Atectura Breezhaler – Product Status 80
Atectura Breezhaler – Product Description 81
Enerzair Breezhaler – Product Status 81
Enerzair Breezhaler – Product Description 81
Next Generation Breezhaler Inhaler – Product Status 82
Next Generation Breezhaler Inhaler – Product Description 82
Novartis AG – Ongoing Clinical Trials Overview 83
Enerzair Breezhaler – A 24-week Prospective, Open-label, Multicenter, Single-arm, Observational Regulatory Post-Marketing Surveillance (rPMS) Study in Real-world Setting (Mandatory by Local HA Regulation) for Enerzair (QVM149 150/50/80 µg o.d. and QVM149 150/50/160 µg o.d. Via Breezhaler) 84
Enerzair Breezhaler – A Double-dummy, Double-blind, Randomized, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Compared to Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. 84
Enerzair Breezhaler – Comparison of Enerziar and Trelegy, Single Inhaler Triple Therapy (SITT), in Asthma 84
Atectura Breezhaler – A 24-week Prospective, Open-label, Multicenter, Single-arm Regulatory Post-Marketing Surveillance (rPMS) Study in Real-world Setting (Mandatory by Local HA Regulation) for Atectura (QMF149 150/80 µg o.d., QMF149 150/160 µg o.d. and QMF149 150/320 µg o.d. Via Breezhaler) 85
Atectura Breezhaler – A Double-dummy, Double-blind, Randomized, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Compared to Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. 85
Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview 86
GelVac Intranasal Powder Vaccine Delivery System – Product Status 86
GelVac Intranasal Powder Vaccine Delivery System – Product Description 86
NanoGENT – Product Status 87
NanoGENT – Product Description 87
OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Inspiromatic – Product Status 88
Inspiromatic – Product Description 88
OtiTopic Inc Pipeline Products & Ongoing Clinical Trials Overview 89
ASPRIHALE – Product Status 89
ASPRIHALE – Product Description 89
Pai Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 90
Inhaled Delivery System – Tuberculosis – Product Status 90
Inhaled Delivery System – Tuberculosis – Product Description 90
Phargentis SA Pipeline Products & Ongoing Clinical Trials Overview 91
Glide DPI – Product Status 91
Glide DPI – Product Description 91
Indacaterol/Glycopyrronium DPI – Product Status 92
Indacaterol/Glycopyrronium DPI – Product Description 92
Pneuma Respiratory Inc Pipeline Products & Ongoing Clinical Trials Overview 93
PNEUMAHALER – Product Status 93
PNEUMAHALER – Product Description 93
Pure Scientific Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 94
PST Closed Loop Heliox Inhaler – Product Status 94
PST Closed Loop Heliox Inhaler – Product Description 94
PureIMS BV Pipeline Products & Ongoing Clinical Trials Overview 95
Amikacin Cyclops – Product Status 95
Amikacin Cyclops – Product Description 95
Epinephrine Cyclops – Product Status 96
Epinephrine Cyclops – Product Description 96
Levodopa Cyclops – Product Status 96
Levodopa Cyclops – Product Description 97
Tobramycin Cyclops – Product Status 97
Tobramycin Cyclops – Product Description 97
PureIMS BV – Ongoing Clinical Trials Overview 98
Levodopa Cyclops – Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson’s Disease Patients 99
Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 100
Dry Powder Inhaler – Product Status 100
Dry Powder Inhaler – Product Description 100
Receptor Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 101
RLS103 – Product Status 101
RLS103 – Product Description 101
Resolve Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview 102
Resolve Go MD – Product Status 102
Resolve Go MD – Product Description 102
Resolve MD – Product Status 102
Resolve MD – Product Description 103
Resolve Mini MD – Product Status 103
Resolve Mini MD – Product Description 103
Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 104
RT234 AOS DPI – Product Status 104
RT234 AOS DPI – Product Description 104
Respirent Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 105
Flovent Diskus – Generic Version – Product Status 105
Flovent Diskus – Generic Version – Product Description 105
Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 106
Pronto Allergy Relief – Product Status 106
Pronto Allergy Relief – Product Description 106
Pronto Focus – Product Status 107
Pronto Focus – Product Description 107
Pronto Nausea Relief – Product Status 107
Pronto Nausea Relief – Product Description 108
Pronto Sleep Performance – Product Status 108
Pronto Sleep Performance – Product Description 108
Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview 109
Solis Multi-Dose Dry Powder Inhaler – Product Status 109
Solis Multi-Dose Dry Powder Inhaler – Product Description 109
Unit-Dose Dry Powder Inhaler – Product Status 110
Unit-Dose Dry Powder Inhaler – Product Description 110
Seng Vital International GmbH Pipeline Products & Ongoing Clinical Trials Overview 111
Cannamed – Product Status 111
Cannamed – Product Description 111
Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview 112
Dry Powder Inhaler – Product Status 112
Dry Powder Inhaler – Product Description 112
Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 113
STS101 Dry Powder Delivery Device – Product Status 113
STS101 Dry Powder Delivery Device – Product Description 113
Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 114
BVA110 – Product Status 114
BVA110 – Product Description 114
DFA001 – Product Status 115
DFA001 – Product Description 115
Softhale NV Pipeline Products & Ongoing Clinical Trials Overview 116
Softhaler – Product Status 116
Softhaler – Product Description 116
Spyryx Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 117
SPX-250 Dry Powder Inhaler – Product Status 117
SPX-250 Dry Powder Inhaler – Product Description 117
Syntara Ltd Pipeline Products & Ongoing Clinical Trials Overview 118
Orbital Dry Powder Inhaler – Product Status 118
Orbital Dry Powder Inhaler – Product Description 118
Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 119
AirDuo Digihaler – Product Status 119
AirDuo Digihaler – Product Description 119
ArmonAir Digihaler – Product Status 120
ArmonAir Digihaler – Product Description 120
Inhaler Device – Product Status 120
Inhaler Device – Product Description 120
ProAir Digihaler – Product Status 121
ProAir Digihaler – Product Description 121
Tidal Inhaler – Product Status 121
Tidal Inhaler – Product Description 122
Teva Pharmaceutical Industries Ltd – Ongoing Clinical Trials Overview 123
ProAir Digihaler – Utilizing Advances in Digital Inhaler Technology to Understand Heterogeneous Treatment Responses to Biologics in Severe Asthma 124
AirDuo Digihaler – Utilizing Advances in Digital Inhaler Technology to Understand Heterogeneous Treatment Responses to Biologics in Severe Asthma 125
Transpire Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 126
CNS Inhaler 1 – Product Status 126
CNS Inhaler 1 – Product Description 126
CNS Inhaler 2 – Product Status 127
CNS Inhaler 2 – Product Description 127
Dry Powder Inhaler (DPI) – Asthma COPD – Product Status 127
Dry Powder Inhaler (DPI) – Asthma COPD – Product Description 128
Dry Powder Inhaler (DPI) – COPD – Product Status 128
Dry Powder Inhaler (DPI) – COPD – Product Description 128
Oncology Inhaler – Product Status 129
Oncology Inhaler – Product Description 129
Soft Mist Inhaler (SMI) – COPD – Product Status 129
Soft Mist Inhaler (SMI) – COPD – Product Description 130
United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 131
Tyvaso DPI – Product Status 131
Tyvaso DPI – Product Description 131
United Therapeutics Corp – Ongoing Clinical Trials Overview 132
Tyvaso DPI – A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2) 133
Tyvaso DPI – A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis 133
Tyvaso DPI – An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis 133
University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 134
Dry Powder Inhaler – Product Status 134
Dry Powder Inhaler – Product Description 134
University of Sydney Pipeline Products & Ongoing Clinical Trials Overview 135
Dry Powder Inhaler – Product Status 135
Dry Powder Inhaler – Product Description 135
University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 136
Dry Powder Drug Delivery System – Product Status 136
Dry Powder Drug Delivery System – Product Description 136
Uscom Ltd Pipeline Products & Ongoing Clinical Trials Overview 137
Spirosonic SmartSpacer – Product Status 137
Spirosonic SmartSpacer – Product Description 137
Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 138
Digitally – Connected LOMI Device – Product Status 138
Digitally – Connected LOMI Device – Product Description 138
MRX006 – Multidose Combined DPI Inhaler – Product Status 139
MRX006 – Multidose Combined DPI Inhaler – Product Description 139
SKP-2075 – Product Status 139
SKP-2075 – Product Description 140
Veoli Ltd Pipeline Products & Ongoing Clinical Trials Overview 141
Cannabis Inhaler Device – Product Status 141
Cannabis Inhaler Device – Product Description 141
Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 142
RPL554 – Dry Powder Inhaler – Product Status 142
RPL554 – Dry Powder Inhaler – Product Description 142
Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 143
Drug Delivery Device – Cystic Fibrosis – Product Status 143
Drug Delivery Device – Cystic Fibrosis – Product Description 143
Dry Powder Inhaler – Product Status 144
Dry Powder Inhaler – Product Description 144
Glossary 184
Buy the Full Report for More Company Insights into the Inhalers Pipeline Market
